FF
STRO icon

FourThought Financial’s Sutro Biopharma STRO Stock Holding History

FourThought Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12K Hold
216
– – ﹤0.01% 998
2022
Q2 		$11K Buy
216
+40
+23% +$2.23K ﹤0.01% 1007
2022
Q1 		$14K Hold
176
– – ﹤0.01% 991
2021
Q4 		$26K Hold
176
– – ﹤0.01% 864
2021
Q3 		$33K Buy
176
+3
+2% +$570 ﹤0.01% 819
2021
Q2 		$32K Sell
173
-9
-5% -$1.76K ﹤0.01% 834
2021
Q1 		$41K Buy
182
+72
+65% +$17.1K 0.01% 740
2020
Q4 		$23K Buy
+110
New +$18.2K ﹤0.01% 848

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

FourThought Financial's STRO Position: Q3 2022 in Review

FourThought Financial held its Sutro Biopharma (STRO) position steady in Q3 2022 at 216 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

FourThought Financial first reported a position in STRO in Q4 2020 and has held it in 8 quarters since. The position peaked at $41K in Q1 2021. 113 funds tracked by Wall St. Rank hold STRO as of Q3 2022.

  • FourThought Financial held 216 shares of Sutro Biopharma worth $12K as of Q3 2022.
  • FourThought Financial left its Sutro Biopharma share count unchanged in Q3 2022.
  • Sutro Biopharma made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #998 holding.
  • FourThought Financial first reported a position in Sutro Biopharma in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Sutro Biopharma position peaked at $41K in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.